fbpx
Medical Innovation Exchange

AbbVie dumps Alector’s Alzheimer’s immunotherapy after phase 1 review

https://www.fiercebiotech.com/biotech/new-approach-old-outcome-abbvie-dumps-alectors-alzheimers-immunotherapy-after-phase-1

Leave a Comment

Your email address will not be published.

Leave the field below empty!

This site uses Akismet to reduce spam. Learn how your comment data is processed.